Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 2001 Mar;91(3):365–368. doi: 10.2105/ajph.91.3.365

The privatization of risk.

B Rockhill 1
PMCID: PMC1446576  PMID: 11236399

Abstract

The privatization, or individualization, of risk factor knowledge has been largely responsible for a rising tide of criticism of epidemiology. The current debate seems polarized into 2 sides, those who support and those who attack "risk factor" epidemiology. This commentary aims to reinvigorate some of Geoffrey Rose's central arguments and show that this debate may miss a key point: a risk factor is a probabilistic concept that applies to an aggregate of individuals, not to a specific individual. Risk factor knowledge compels those in public health to seek actions that shift population distributions of these factors and, to do so, to understand their social, economic, and political determinants. The author links Rose's qualitative distinction between the causes of cases and the causes of incidence to an examination of the conceptual and quantitative limits of "individual risk" estimation. The attempt to predict individuals' futures on the basis of risk factor profile is especially prominent now with breast cancer. The author suggests reasons why a policy promoting private decision making about risk, while likely ineffective from a population standpoint, is viewed as the only feasible primary prevention option against this disease.

Full Text

The Full Text of this article is available as a PDF (62.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burris S. The invisibility of public health: population-level measures in a politics of market individualism. Am J Public Health. 1997 Oct;87(10):1607–1610. doi: 10.2105/ajph.87.10.1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fisher B., Costantino J. P., Wickerham D. L., Redmond C. K., Kavanah M., Cronin W. M., Vogel V., Robidoux A., Dimitrov N., Atkins J. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371–1388. doi: 10.1093/jnci/90.18.1371. [DOI] [PubMed] [Google Scholar]
  3. Gail M. H., Brinton L. A., Byar D. P., Corle D. K., Green S. B., Schairer C., Mulvihill J. J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989 Dec 20;81(24):1879–1886. doi: 10.1093/jnci/81.24.1879. [DOI] [PubMed] [Google Scholar]
  4. Gail M. H., Costantino J. P., Bryant J., Croyle R., Freedman L., Helzlsouer K., Vogel V. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst. 1999 Nov 3;91(21):1829–1846. doi: 10.1093/jnci/91.21.1829. [DOI] [PubMed] [Google Scholar]
  5. Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15;117(12):1016–1037. doi: 10.7326/0003-4819-117-12-1016. [DOI] [PubMed] [Google Scholar]
  6. Grodstein F., Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Joffe M., Rosner B., Fuchs C., Hankinson S. E., Hunter D. J. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997 Jun 19;336(25):1769–1775. doi: 10.1056/NEJM199706193362501. [DOI] [PubMed] [Google Scholar]
  7. Harrell F. E., Jr, Lee K. L., Mark D. B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996 Feb 28;15(4):361–387. doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  8. Harris J. R., Lippman M. E., Veronesi U., Willett W. Breast cancer (1) N Engl J Med. 1992 Jul 30;327(5):319–328. doi: 10.1056/NEJM199207303270505. [DOI] [PubMed] [Google Scholar]
  9. Hartmann L. C., Schaid D. J., Woods J. E., Crotty T. P., Myers J. L., Arnold P. G., Petty P. M., Sellers T. A., Johnson J. L., McDonnell S. K. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999 Jan 14;340(2):77–84. doi: 10.1056/NEJM199901143400201. [DOI] [PubMed] [Google Scholar]
  10. Hunter D. J., Willett W. C. Diet, body size, and breast cancer. Epidemiol Rev. 1993;15(1):110–132. doi: 10.1093/oxfordjournals.epirev.a036096. [DOI] [PubMed] [Google Scholar]
  11. KANNEL W. B., DAWBER T. R., KAGAN A., REVOTSKIE N., STOKES J., 3rd Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med. 1961 Jul;55:33–50. doi: 10.7326/0003-4819-55-1-33. [DOI] [PubMed] [Google Scholar]
  12. Krieger N. Epidemiology and the web of causation: has anyone seen the spider? Soc Sci Med. 1994 Oct;39(7):887–903. doi: 10.1016/0277-9536(94)90202-x. [DOI] [PubMed] [Google Scholar]
  13. Longnecker M. P. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control. 1994 Jan;5(1):73–82. doi: 10.1007/BF01830729. [DOI] [PubMed] [Google Scholar]
  14. Marmot M. G. Improvement of social environment to improve health. Lancet. 1998 Jan 3;351(9095):57–60. doi: 10.1016/S0140-6736(97)08084-7. [DOI] [PubMed] [Google Scholar]
  15. Pearce N. Traditional epidemiology, modern epidemiology, and public health. Am J Public Health. 1996 May;86(5):678–683. doi: 10.2105/ajph.86.5.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rimm E. B., Williams P., Fosher K., Criqui M., Stampfer M. J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999 Dec 11;319(7224):1523–1528. doi: 10.1136/bmj.319.7224.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rockhill B, Colditz G, Kaye J. Re: tamoxifen prevention of breast cancer: an instance of the fingerpost. J Natl Cancer Inst. 2000 Apr 19;92(8):657A–6657. [PubMed] [Google Scholar]
  18. Rose G., Day S. The population mean predicts the number of deviant individuals. BMJ. 1990 Nov 3;301(6759):1031–1034. doi: 10.1136/bmj.301.6759.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985 Mar;14(1):32–38. doi: 10.1093/ije/14.1.32. [DOI] [PubMed] [Google Scholar]
  20. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981 Jun 6;282(6279):1847–1851. doi: 10.1136/bmj.282.6279.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rothman K. J., Adami H. O., Trichopoulos D. Should the mission of epidemiology include the eradication of poverty? Lancet. 1998 Sep 5;352(9130):810–813. doi: 10.1016/s0140-6736(98)01327-0. [DOI] [PubMed] [Google Scholar]
  22. Russo J., Gusterson B. A., Rogers A. E., Russo I. H., Wellings S. R., van Zwieten M. J. Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990 Mar;62(3):244–278. [PubMed] [Google Scholar]
  23. Russo J., Russo I. H. Biological and molecular bases of mammary carcinogenesis. Lab Invest. 1987 Aug;57(2):112–137. [PubMed] [Google Scholar]
  24. Schwartz S., Susser E., Susser M. A future for epidemiology? Annu Rev Public Health. 1999;20:15–33. doi: 10.1146/annurev.publhealth.20.1.15. [DOI] [PubMed] [Google Scholar]
  25. Siiteri P. K. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987 Jan;45(1 Suppl):277–282. doi: 10.1093/ajcn/45.1.277. [DOI] [PubMed] [Google Scholar]
  26. Smith-Warner S. A., Spiegelman D., Yaun S. S., van den Brandt P. A., Folsom A. R., Goldbohm R. A., Graham S., Holmberg L., Howe G. R., Marshall J. R. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998 Feb 18;279(7):535–540. doi: 10.1001/jama.279.7.535. [DOI] [PubMed] [Google Scholar]
  27. Susser M. Does risk factor epidemiology put epidemiology at risk? Peering into the future. J Epidemiol Community Health. 1998 Oct;52(10):608–611. doi: 10.1136/jech.52.10.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Thun M. J., Peto R., Lopez A. D., Monaco J. H., Henley S. J., Heath C. W., Jr, Doll R. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997 Dec 11;337(24):1705–1714. doi: 10.1056/NEJM199712113372401. [DOI] [PubMed] [Google Scholar]
  29. Toulmin S. On the nature of the physician's understanding. J Med Philos. 1976 Mar;1(1):32–50. doi: 10.1093/jmp/1.1.32. [DOI] [PubMed] [Google Scholar]
  30. Wald N. J., Hackshaw A. K., Frost C. D. When can a risk factor be used as a worthwhile screening test? BMJ. 1999 Dec 11;319(7224):1562–1565. doi: 10.1136/bmj.319.7224.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998 Mar 4;279(9):688–695. doi: 10.1001/jama.279.9.688. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES